Discontinued — last reported Q4 '25
Rocket Lab USA, Inc. Interest Paid increased by 27.8% to $3.39M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 64.6%, from $9.58M to $3.39M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 57.5% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $1.92M | $2.07M | $2.29M | $2.48M | $2.82M | $3.16M | $3.42M | $3.63M | $3.69M | $4.81M | $2.27M | $2.32M | $9.65M | $2.05M | $9.58M | $2.72M | $9.59M | $2.66M | $3.39M |
| QoQ Change | — | — | +7.6% | +10.8% | +8.2% | +13.9% | +11.8% | +8.3% | +6.4% | +1.5% | +30.4% | -52.8% | +2.1% | +316.3% | -78.8% | +367.3% | -71.6% | +252.2% | -72.3% | +27.8% |
| YoY Change | — | — | — | — | — | +46.9% | +52.5% | +49.1% | +46.6% | +30.7% | +52.5% | -33.6% | -36.2% | +161.5% | -57.4% | +321.8% | +17.5% | -0.6% | +29.6% | -64.6% |